Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00141193 · ClinicalTrials.gov registry record · Phase 3
Prevention of Colorectal Sporadic Adenomatous Polyps (PRESAP)
A Phase 3 study of Colorectal Adenoma, sponsored by Pfizer.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,561
- Enrollment target
- 20
- Study locations
NCT00141193: Completed Phase 3 study of Colorectal Adenoma, sponsored by Pfizer.
NCT00141193 is a Phase 3 study of Colorectal Adenoma that has completed, run by Pfizer. The registered enrollment target is 1,561 participants, above the 1,235-participant average among 8 other Colorectal Adenoma trials with a reported enrollment target (26% higher). The trial reports 20 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00141193, a Phase 3 study of Colorectal Adenoma, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,561 participants
- Enrollment target
- 20
- Study locations
Study Summary
This study is a prospective, randomized, double-blind, placebo-controlled, multi-center trial to compare the efficacy and safety of celecoxib 400mg QD versus placebo in reducing the occurrence of new colorectal adenomas post-polypectomy at Month 13 (Year 1) and Month 37 (Year 3) of study drug administration.
Conditions Studied
Interventions
- DRUG Celecoxib
Study Locations (20)
Other
- Pfizer Investigational Site - Brussels
- Pfizer Investigational Site - Brussels
- Pfizer Investigational Site - Brussels
- Pfizer Investigational Site - Ghent
California
- Pfizer Investigational Site - San Diego
- Pfizer Investigational Site - San Kiego
Illinois
- Pfizer Investigational Site - North Chicago
- Pfizer Investigational Site - Oak Park
Maryland
- Pfizer Investigational Site - Baltimore
- Pfizer Investigational Site - Baltimore
Pennsylvania
- Pfizer Investigational Site - Philadelphia
- Pfizer Investigational Site - Philadelphia
Texas
- Pfizer Investigational Site - Houston
Virginia
- Pfizer Investigational Site - Richmond
Queensland
- Pfizer Investigational Site - Townsville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,561 participants |
| Start Date | 2001-02 |
| Est. Completion | 2007-05 |
| Phase | Phase 3 |
What the finished NCT00141193 record still lists
NCT00141193 is an interventional study that assigns participants to a tested intervention. Its 1,561 participants enrollment target places it among the larger protocols in the corpus, above the 1,235-participant average among 8 other Colorectal Adenoma trials with a reported enrollment target (26% higher).
The record links to 1 condition, with Colorectal Adenoma appearing as the primary indexed condition, and to 1 intervention - of which Celecoxib is the first listed.
NCT00141193 names 20 study sites across 13 states, led by Other, California, Illinois.
Frequently Asked Questions
What is clinical trial NCT00141193 about?
NCT00141193 is a clinical study titled "Prevention of Colorectal Sporadic Adenomatous Polyps (PRESAP)". This study is a prospective, randomized, double-blind, placebo-controlled, multi-center trial to compare the efficacy and safety of celecoxib 400mg QD versus placebo in reducing the occurrence of new colorectal adenomas post-polypectomy at Month 13 (Year 1) and Month 37 (Year 3) of study drug admini...
What is the current status of trial NCT00141193?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,561 participants. The study started on 2001-02. Estimated completion is 2007-05.
What conditions does trial NCT00141193 study?
This clinical trial studies the following conditions: Colorectal Adenoma.
What interventions are being tested in trial NCT00141193?
The interventions under investigation include: Celecoxib (DRUG).
Who is sponsoring clinical trial NCT00141193?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00141193 being conducted?
This trial has 20 study locations across California, Illinois, Maryland, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Adenoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00141193's enrollment target sits among peer trials
1,561 2nd of 8 the highest of 8 other Colorectal Adenoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Colorectal Adenoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of Gixam's Performance in a FIT Negative Population
RECRUITING · Phase 2
-
Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal Tumors
RECRUITING · Phase 1
-
PARADIGM - En Bloc Trial With the EndoQuest Endoluminal Surgical (ELS) System
RECRUITING · NA
-
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
RECRUITING · NA
-
Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps
ACTIVE NOT RECRUITING · Phase 2
-
Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma
ACTIVE NOT RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06881069 · 1,560 participants · NA
Reach Through Equitable Implementation in Utah
- NCT06034080 · 1,566 participants · NA
Interventions to De-implement Unnecessary Antibiotic Prescribing for Children With Ear Infections
- NCT06445946 · 1,572 participants · Phase 4
DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes
- NCT02650622 · 1,550 participants
Genetic and Metabolic Disease in Children
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia